Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-02-26

Clinical Trial Update: H5-VLP + GLA-AF Vaccine Trial in Healthy Adult Volunteers [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the H5-VLP + GLA-AF influenza vaccine in healthy adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • H5-VLP + GLA-AF Vaccine

Snippet

Sponsor: Access to Advanced Health Institute (AAHI) | Conditions: Influenza A Subtype H5N1 Infection | Phase 1 | Status: COMPLETED